BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thelen A, Jonas S, Benckert C, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhaus P. Liver resection for metastases from renal cell carcinoma. World J Surg. 2007;31:802-807. [PMID: 17354021 DOI: 10.1007/s00268-007-0685-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Schwarz C, Kaczirek K, Bodingbauer M. Liver resection for non-colorectal metastases. Eur Surg 2018;50:113-6. [PMID: 29875799 DOI: 10.1007/s10353-018-0528-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Decoene J, Ameye F, Lerut E, Oyen R, Van Poppel H, Joniau S. Renal cell carcinoma with synchronous metastasis to the calcaneus and metachronous metastases to the ovary and gallbladder. Case Rep Med 2011;2011:671645. [PMID: 22028725 DOI: 10.1155/2011/671645] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
3 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
4 Puente Vázquez J, Alonso Gordoa T, Moreno J, Poma L, Diaz Rubio E, Gomez A, Blazquez J, Gonzalez Larriba JL. New Challenges in Kidney Cancer Management: Integration of Surgery and Novel Therapies. Curr Treat Options in Oncol 2015;16. [DOI: 10.1007/s11864-015-0337-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Roos FC, Thüroff JW. [Resecting hematogenous metastases: reasons against]. Urologe A 2014;53:817-22. [PMID: 24824465 DOI: 10.1007/s00120-014-3467-7] [Reference Citation Analysis]
6 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
7 Pinotti E, Montuori M, Giani A, Uggeri F, Garancini M, Gianotti L, Romano F. Surgical treatment of liver metastases from kidney cancer: a systematic review. ANZ J Surg. 2019;89:32-37. [PMID: 30685878 DOI: 10.1111/ans.15000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Staehler M, Haseke N, Zilinberg E, Stadler T, Karl A, Siebels M, Dürr H, Siegert S, Jauch KW, Bruns CJ, Stief CG. Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urologic Oncology: Seminars and Original Investigations 2010;28:139-44. [DOI: 10.1016/j.urolonc.2009.03.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
9 Verbiest A, Couchy G, Job S, Caruana L, Lerut E, Oyen R, de Reyniès A, Tosco L, Joniau S, Van Poppel H, Van Raemdonck D, Van Den Eynde K, Wozniak A, Zucman-Rossi J, Beuselinck B. Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy. Eur Urol 2018;74:474-80. [PMID: 29463434 DOI: 10.1016/j.eururo.2018.01.042] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
10 Mennitto A, Verzoni E, Grassi P, Ratta R, Fucà G, Procopio G. Multimodal treatment of advanced renal cancer in 2017. Expert Review of Clinical Pharmacology 2017;10:1395-402. [DOI: 10.1080/17512433.2017.1386552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 Tan MC, Jarnagin WR. Surgical management of non-colorectal hepatic metastasis: Non-Colorectal Metastatectomy. J Surg Oncol 2014;109:8-13. [DOI: 10.1002/jso.23462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Burger M. [Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?]. Urologe A 2017;56:617-23. [PMID: 28314970 DOI: 10.1007/s00120-017-0357-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Brehmer B, Piper C, Pfister D, Porres D, Heidenreich A. [Metastasectomy for renal cell cancer]. Urologe A 2012;51:1202-8. [PMID: 22733397 DOI: 10.1007/s00120-012-2872-z] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Martel G, Bertens KA, Canil C. Surgical Management of Genitourinary Cancer Liver Metastases. Surg Oncol Clin N Am 2021;30:89-102. [PMID: 33220811 DOI: 10.1016/j.soc.2020.08.003] [Reference Citation Analysis]
15 Wahba R, Stippel D, Bruns C. Die Rolle der Viszeralchirurgie bei Oligometastasierung nichtgastrointestinaler Tumoren. Chirurg 2018;89:523-8. [DOI: 10.1007/s00104-018-0647-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ruys AT, Tanis PJ, Nagtegaal ID, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol. 2011;18:1932-1938. [PMID: 21347794 DOI: 10.1245/s10434-010-1526-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
17 Bonnet S, Gaujoux S, Leconte M, Thillois JM, Tissier F, Dousset B. Laparoscopic adrenalectomy for metachronous metastasis from renal cell carcinoma. World J Surg 2008;32:1809-14. [PMID: 18330621 DOI: 10.1007/s00268-008-9539-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
19 Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543-547. [PMID: 20440505 DOI: 10.1007/s00345-010-0560-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
20 Bex A. Integrating metastasectomy and stereotaxic radiosurgery in the treatment of metastatic renal cell carcinoma. EJC Supplements. 2013;2:192-203. [PMID: 26217128 DOI: 10.1016/j.ejcsup.2013.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Ruiz-Cerdá JL, Jiménez Cruz F. [Surgical treatment for renal cancer metastases]. Actas Urol Esp 2009;33:593-602. [PMID: 19658314 DOI: 10.1016/s0210-4806(09)74194-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Montero PH, Ibrahimpasic T, Nixon IJ, Shaha AR. Thyroid metastasectomy. J Surg Oncol 2014;109:36-41. [PMID: 24122778 DOI: 10.1002/jso.23452] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
23 Ruutu M, Bono P, Taari K. Resection of Renal Cell Cancer Metastases: Where Do We Stand in 2008? European Urology Supplements 2008;7:436-42. [DOI: 10.1016/j.eursup.2008.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
24 Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology 2017;99:155-61. [DOI: 10.1016/j.urology.2016.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
25 Omid S, Abufaraj M, Remzi M. Metastasectomy in patients with renal cell carcinoma: when and how? Curr Opin Urol 2020;30:602-9. [PMID: 32464043 DOI: 10.1097/MOU.0000000000000768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012;14:532-538. [PMID: 22762401 DOI: 10.1111/j.1477-2574.2012.00495.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
27 Pikoulis E, Margonis GA, Antoniou E. Surgical Management of Renal Cell Cancer Liver Metastases. Scand J Surg 2016;105:263-8. [PMID: 26929295 DOI: 10.1177/1457496916630644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Sellner F. Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations. Front Oncol 2020;10:709. [PMID: 32547940 DOI: 10.3389/fonc.2020.00709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Grimes NG, Devlin JM, Dunne DF, Jones RP, Poston GJ, Fenwick SW, Malik HZ. A systematic review of the role of hepatectomy in the management of metastatic renal cell carcinoma. Eur J Surg Oncol. 2014;40:1622-1628. [PMID: 25228053 DOI: 10.1016/j.ejso.2014.08.472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 Nixon IJ, Coca-Pelaz A, Kaleva AI, Triantafyllou A, Angelos P, Owen RP, Rinaldo A, Shaha AR, Silver CE, Ferlito A. Metastasis to the Thyroid Gland: A Critical Review. Ann Surg Oncol 2017;24:1533-9. [PMID: 27873099 DOI: 10.1245/s10434-016-5683-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
31 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
32 Geisel D, Collettini F, Denecke T, Grieser C, Flörcken A, Wust P, Hamm B, Gebauer B. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series. World J Urol 2013;31:1525-30. [PMID: 23132612 DOI: 10.1007/s00345-012-0981-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
33 Thelen A, Jonas S, Benckert C, Lopez-hänninen E, Neumann U, Rudolph B, Schumacher G, Neuhaus P. Liver resection for metastatic gastric cancer. European Journal of Surgical Oncology (EJSO) 2008;34:1328-34. [DOI: 10.1016/j.ejso.2008.01.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
34 Mejean A, Correas JM, Escudier B, de Fromont M, Lang H, Long JA, Neuzillet Y, Patard JJ, Piechaud T. [Kidney tumors]. Prog Urol 2007;17:1101-44. [PMID: 18153989 DOI: 10.1016/s1166-7087(07)74782-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
35 Achkar T, Maranchie JK, Appleman LJ. Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review. KCA 2019;3:31-40. [DOI: 10.3233/kca-180042] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van Poppel H, Bensalah K; Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur Urol Oncol. 2019;2:141-149. [PMID: 31017089 DOI: 10.1016/j.euo.2018.08.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
37 Husillos Alonso A, Carbonero García M, González Enguita C. Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma? World J Nephrol 2015; 4(2): 254-262 [PMID: 25949939 DOI: 10.5527/wjn.v4.i2.254] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
38 Loh J, Davis ID, Martin JM, Siva S. Extracranial oligometastatic renal cell carcinoma: current management and future directions. Future Oncol 2014;10:761-74. [PMID: 24799057 DOI: 10.2217/fon.14.40] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
39 Nabil M, Gruber T, Yakoub D, Ackermann H, Zangos S, Vogl TJ. Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: Local control and survival results. Eur Radiol 2008;18:1456-63. [DOI: 10.1007/s00330-008-0887-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
40 Beetz O, Söffker R, Cammann S, Oldhafer F, Vondran FWR, Imkamp F, Klempnauer J, Kleine M. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg 2020;405:97-106. [PMID: 31938833 DOI: 10.1007/s00423-019-01852-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int 2012;109:631-7. [PMID: 23093995 DOI: 10.3238/arztebl.2012.0631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
42 Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE, Russo P. Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites. J Surg Oncol 2016;114:375-9. [PMID: 27338155 DOI: 10.1002/jso.24327] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
43 Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 2011;6:34. [PMID: 21477295 DOI: 10.1186/1748-717X-6-34] [Cited by in Crossref: 100] [Cited by in F6Publishing: 53] [Article Influence: 9.1] [Reference Citation Analysis]
44 Kulik U, Lehner F, Bektas H, Klempnauer J. Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications. Viszeralmedizin 2015;31:394-8. [PMID: 26889142 DOI: 10.1159/000439419] [Reference Citation Analysis]
45 Bhutiani N, Philips P, Martin RC 2nd, Scoggins CR. Impact of surgical margin clearance for resection of secondary hepatic malignancies. J Surg Oncol. 2016;113:289-295. [PMID: 26662026 DOI: 10.1002/jso.24107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
46 Hau HM, Thalmann F, Lübbert C, Morgul MH, Schmelzle M, Atanasov G, Benzing C, Lange U, Ascherl R, Ganzer R, Uhlmann D, Tautenhahn HM, Wiltberger G, Bartels M. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy. BMC Surg 2016;16:49. [PMID: 27444582 DOI: 10.1186/s12893-016-0163-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]